共 19 条
[1]
Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?
[J].
IMMUNOLOGY TODAY,
1998, 19 (01)
:2-5
[2]
Altenschmidt U, 1997, J IMMUNOL, V159, P5509
[4]
DIEHL V, 1984, J CANCER RES CLIN, V101, P411
[5]
ENGERT A, 1990, CANCER RES, V50, P2929
[6]
SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS
[J].
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,
1993, 90 (02)
:720-724
[8]
Hombach A, 1998, CANCER RES, V58, P1116
[9]
Hombach A, 1998, SCAND J IMMUNOL, V48, P497